BioArctic signed the first deal for its “brain transporter” with Bristol Myers Squibb late last year. The deal is worth up to $1.4bn and allows the US drugmaker to start trials using the technology to ...

BC Partners has appointed Rothschild to explore strategic options for the business, according to two people familiar with the situation. A sale could raise as much as €550mn, they added, with rival ...

It had been expected that Vance would use his speech at the Munich Security Conference to address possible talks to end the ...